A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market

Off Health News

Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.

View original article
Contributor: Pam Belluck

About The Author